Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decline Co-morbidity Among Older Black Individuals in the Community; The Feeling of Being Open Pilot

NCT ID: NCT07210398

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-05

Study Completion Date

2025-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to pilot an adaptation of mindfulness-based cognitive therapy for chronic pain and early cognitive decline. The main questions it aims to answer in a later fully powered randomized controlled trial are:

* Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life?
* Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Co-morbid chronic pain and early cognitive decline is common among older Black adults and this co-morbidity worsens physical and cognitive function. Access to evidence based non-pharmacological management is limited. Mindfulness based cognitive therapy (MBCT) is an evidence-based, non-pharmacological intervention that could address the chronic pain and early cognitive decline co-morbidity among older Black adults, but it requires tailoring. The proposed study will establish the feasibility, acceptability and credibility of Feeling of Being, a cultural adaptation of MBCT aimed at the chronic pain and early cognitive decline co-morbidity among older Black adults in the community.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Early Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Feeling of Being

Group Type EXPERIMENTAL

Quiet Focus

Intervention Type BEHAVIORAL

Mindfulness-based cognitive therapy adapted for older adults at-risk for chronic pain and depression

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quiet Focus

Mindfulness-based cognitive therapy adapted for older adults at-risk for chronic pain and depression

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older adult (age ≥ 50)
* All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
* Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months
* Early Cognitive Decline (subjective or MCI)
* Telephone Interview for Cognitive Status-41 score ≥ 26
* Functional Activities Questionnaire score \< 9
* English fluency/literacy
* Ability and willingness to participate via in-person and video
* Willing to provide informed consent and comply with all aspects of the protocol

Exclusion Criteria

* Current substance abuse/dependence
* Significant cognitive impairment
* History of more than 8 sessions of cognitive-behavioral therapy
* History of previous training in mindfulness or undergoing counseling more than once a month
* History of or current diagnosis of psychosis
* Active suicidal ideation or self-harm within the past 90 days
Minimum Eligible Age

50 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Advancing Translational Sciences (NCATS)

NIH

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tony V. Pham, MD

Principal Investigator and Psychiatrist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tony V Pham

Role: PRINCIPAL_INVESTIGATOR

MGH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UM1TR004408

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2024P002081

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.